Brief: RhoVac AB Says First Patient In Finland has Started Treatment In BRaVac Clinical Study

Chosa Oncology AB

03/03/2020 14:11

March 3 (Reuters) - RhoVac AB  RHOVAC.TE :
    * RHOVAC AB - FIRST PATIENT IN FINLAND STARTED TREATMENT IN
CO'S
CLINICAL PHASE IIB STUDY IN PROSTATE CANCER, A STUDY ENTITLED
RHOVAC-002
    * RHOVAC AB - RESULTS REPORT ON ACTIVE TREATMENT PART OF
RHOVAC-002 STUDY IS EXPECTED IN H2 2021

Source text for Eikon:  ID:nPnbZ83zDa 
Further company coverage:  RHOVAC.TE 

 ((Reuters.Briefs@thomsonreuters.com;))